Found to inhibit HCV activity by approximately 90% Data from a late-breaking abstract presented at the International Liver CongressTM 2014 identifies a new compound, SBEL1, that ha... Read more
The Holy Grail of nanotherapy University of Florida researchers have moved a step closer to treating diseases on a cellular level by creating a tiny particle that can be programmed... Read more
It will take at least five years before the vaccine can be put forwards for regulatory approval After many years of research a group of Canadian scientists have announced a possibl... Read more
It may be five to seven years before the vaccine receives approval A University of Alberta researcher and Canada Excellence Research Chair in Virology has made the discovery... Read more
The treatment of hepatitis C virus infections has taken a major step forward with the U.S. Food and Drug Administration’s approval of two new drugs, telaprevir and boceprevir, for... Read more
